(Q44256933)

English

Basiliximab-sirolimus-prednisone induction regimen followed by delayed low-dose cyclosporine in renal transplant recipients of living donors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Basiliximab-sirolimus-prednisone induction regimen followed by delayed low-dose cyclosporine in renal transplant recipients of living donors (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

based on heuristic

inferred from title

author name string

R M Langer

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

D M Hong

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

S M Katz

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

C T Van Buren

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

3162-3164

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Cyclosporin A in patients receiving renal allografts from cadaver donors

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of acute rejection using basiliximab with triple immunosuppression in cadaveric kidney recipients in first three months

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-7 and IL-15 bypass the immunosuppressive action of anti-CD25 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic analysis of basiliximab in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibody basiliximab with low cyclosporine dose as initial immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Can antibody prophylaxis allow sparing of other immunosuppressives?

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-CD25 monoclonal antibody coverage allows for calcineurin inhibitor "holiday" in solid organ transplant patients with acute renal dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903565-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0041-1345(02)03565-0

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44256933&oldid=2108945423"